Vitalhub (TSE:VHI – Get Free Report) has been assigned a C$7.50 price objective by stock analysts at Cormark in a research note issued on Monday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Cormark’s target price points to a potential upside of 24.17% from the stock’s previous close.
A number of other analysts also recently commented on the company. Canaccord Genuity Group raised their price objective on Vitalhub from C$5.25 to C$5.50 and gave the stock a “buy” rating in a research report on Tuesday, February 6th. Eight Capital raised their price objective on Vitalhub from C$5.00 to C$6.25 and gave the stock a “buy” rating in a research report on Tuesday, February 6th.
View Our Latest Research Report on Vitalhub
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings results on Thursday, March 21st. The company reported C$0.03 EPS for the quarter, missing the consensus estimate of C$0.04 by C($0.01). Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. The firm had revenue of C$13.60 million during the quarter, compared to analyst estimates of C$13.68 million. As a group, equities analysts forecast that Vitalhub will post 0.1501823 earnings per share for the current fiscal year.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
- Five stocks we like better than Vitalhub
- How to Use the MarketBeat Stock Split Calculator
- The Charles Schwab Company Can Hit New Highs
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- EV Stocks and How to Profit from Them
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.